24 HR Propranolol Hydrochloride 160 MG Extended Release Oral Capsule
INDICATIONS AND USAGE Hypertension Propranolol Hydrochloride Extended-Release Capsules are indicated in the management of hypertension. It may be used alone or used in combination with other antihypertensive agents, particularly a thiazide diuretic. Propranolol Hydrochloride Extended-Release Capsules are not indicated in the management of hypertensive emergencies. Angina Pectoris Due to Coronary Atherosclerosis Propranolol Hydrochloride Extended-Release Capsules are indicated to decrease angina frequency and increase exercise tolerance in patients with angina pectoris. Migraine Propranolol Hydrochloride Extended-Release Capsules are indicated for the prophylaxis of common migraine headache. The efficacy of propranolol in the treatment of a migraine attack that has started has not been established, and propranolol is not indicated for such use. Hypertrophic Subaortic Stenosis Propranolol Hydrochloride Extended-Release Capsules improve NYHA functional class in symptomatic patients with Hypertrophic Subaortic Stenosis.
lannett company, inc.
CAPSULE BLUE A 104
Related Pills
24 HR Propranolol Hydrochloride 60 MG Extended Release Oral Capsule
lannett company, inc.
24 HR Propranolol Hydrochloride 80 MG Extended Release Oral Capsule
lannett company, inc.
24 HR Propranolol Hydrochloride 120 MG Extended Release Oral Capsule
lannett company, inc.
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
HOW SUPPLIED
PROPRANOLOL HYDROCHLORIDE Extended-Release capsules, USP 60 mg, capsule # 3, Opaque white cap printed with in black ink; Opaque light blue body printed with 107 in black ink. NDC 0527-4116-37, bottle of 100 capsules with child-resistant closure NDC 0527-4116-41, bottle of 500 capsules 80 mg, capsule # 3, Opaque light blue cap printed with in black ink; Opaque light blue body printed with 106 in black ink. NDC 0527-4117-37, bottle of 100 capsules with child-resistant closure NDC 0527-4117-41, bottle of 500 capsules 120 mg, capsule # 2, Opaque light blue cap printed with in black ink; Opaque brilliant blue body printed with 105 in black ink. NDC 0527-4118-37, bottle of 100 capsules with child-resistant closure NDC 0527-4118-41, bottle of 500 capsules 160 mg, capsule # 1, Opaque brilliant blue cap printed with in black ink; Opaque brilliant blue body printed with 104 in black ink. NDC 0527-4119-37, bottle of 100 capsules with child-resistant closure NDC 0527-4119-41, bottle of 500 capsules Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F). [See USP Controlled Room Temperature] Protect from light, moisture, freezing, and excessive heat. Dispense in a tight, light-resistant container as defined in the USP with a child-resistant closure. Keep this and all medication out of the reach of children. For medical inquires, contact Lannett Company, Inc. at 1-844-834-0530. Distributed by: Lannett Company, Inc. Philadelphia, PA 19136 Manufactured by: Yichang Humanwell Oral Solid Dosage Plant Yichang, Hubei, China 443001 L7037C Rev. 02/2024 ink ink ink ink
More pills like CAPSULE A 104